Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
Titel:
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
Auteur:
Boorjian, Stephen A Alemozaffar, Mehrdad Konety, Badrinath R Shore, Neal D Gomella, Leonard G Kamat, Ashish M Bivalacqua, Trinity J Montgomery, Jeffrey S Lerner, Seth P Busby, Joseph E Poch, Michael Crispen, Paul L Steinberg, Gary D Schuckman, Anne K Downs, Tracy M Svatek, Robert S Mashni Jr, Joseph Lane, Brian R Guzzo, Thomas J Bratslavsky, Gennady Karsh, Lawrence I Woods, Michael E Brown, Gordon Canter, Daniel Luchey, Adam Lotan, Yair Krupski, Tracey Inman, Brant A Williams, Michael B Cookson, Michael S Keegan, Kirk A Andriole Jr, Gerald L Sankin, Alexander I Boyd, Alan O'Donnell, Michael A Sawutz, David Philipson, Richard Coll, Ruth Narayan, Vikram M Treasure, F Peter Yla-Herttuala, Seppo Parker, Nigel R Dinney, Colin P N